Full Spectrum Oil vs Flower: Which is Better for UK Patients?

Full Spectrum Oil vs Flower: A Practical Guide for UK Medical Cannabis Patients

Two of the most commonly prescribed medical cannabis formats in the UK are dried flower (for vaporisation) and full spectrum oils (sublingual). Many patients are prescribed one or both — but understanding the differences can help you have a more informed conversation with your prescriber and get better results from your treatment.

This guide compares both formats across onset time, duration, bioavailability, cost, discretion, and condition suitability.

What Is Full Spectrum Cannabis Oil?

Full spectrum cannabis oil contains the complete range of cannabinoids, terpenes, and phytochemicals present in the cannabis plant — including THC, CBD, CBG, CBN, and a broad terpene profile. This is distinct from:

• Broad spectrum oil: Similar to full spectrum but with THC removed or reduced below detectable levels.
• CBD isolate oil: Contains only purified CBD, no other cannabinoids.

Full spectrum preparations are thought to deliver the entourage effect — the synergistic interaction of multiple cannabinoids and terpenes that may enhance therapeutic outcomes beyond any single compound alone. Most UK prescribed medicinal cannabis oils are full or broad spectrum.

What Is Medical Cannabis Flower?

Prescribed medical cannabis flower in the UK is dried, pharmaceutical-grade cannabis bud intended for use in a medical-grade dry herb vaporiser. UK patients are not prescribed cannabis for combustion (smoking). Flower can be indica-dominant, sativa-dominant, or hybrid, with varying cannabinoid and terpene profiles.

Browse UK medical cannabis strain profiles to compare available flower varieties.

Head-to-Head Comparison

Onset Speed

• Flower (vaporised): 5–15 minutes. Ideal for acute, breakthrough symptoms requiring rapid relief.
• Full spectrum oil (sublingual): 15–45 minutes. Faster than oral ingestion but slower than vaporisation.

Winner for speed: Flower.

Duration of Effect

• Flower: 2–4 hours typically. Shorter duration suits patients who need flexible, on-demand dosing.
• Oil: 4–8 hours. More sustained blood levels suit conditions requiring consistent symptom management throughout the day or night.

Winner for duration: Oil.

Bioavailability

• Flower (vaporised): Pulmonary bioavailability is approximately 20–56%, varying with vaporiser technique and temperature.
• Oil (sublingual): Partial absorption through oral mucosa (~6–20% sublingual) plus gastrointestinal absorption. Total bioavailability is typically lower than vaporisation but more predictable.

Winner for bioavailability: Flower (when used correctly with an appropriate vaporiser).

Dose Precision

• Flower: Dose precision is moderate — depends on the amount loaded, vaporiser temperature, and inhalation technique. Consistent results require practice and standardised technique.
• Oil: High dose precision — measured in drops or millilitres from a calibrated dropper. Easier to titrate precisely. Use our dosage calculator for oil titration guidance.

Winner for precision: Oil.

Cost

• Flower: £6–£14/g in the UK. A typical patient using 1g/day spends £180–£420/month on flower alone.
• Oil: £40–£120 per 10ml bottle. For many patients, monthly oil costs of £80–£200 represent lower spend than equivalent flower dosing.

Winner for cost: Usually oil — particularly for patients requiring lower-to-moderate doses.

Discretion and Convenience

• Flower: Requires a vaporiser device, produces visible vapour and some aroma. Less discreet for use outside the home.
• Oil: Small bottle, odourless, can be dosed anywhere discretely with no equipment required.

Winner for discretion: Oil.

Respiratory Considerations

• Flower: Not suitable for patients with asthma, COPD, or significant respiratory conditions, even when vaporised rather than smoked.
• Oil: No respiratory impact. Preferred for patients with lung conditions.

Winner for respiratory safety: Oil.

Which Conditions Suit Each Format?

Conditions Where Flower Often Performs Better

• Breakthrough or acute pain requiring rapid relief.
• Acute anxiety episodes.
• Acute nausea (e.g. chemotherapy-related).
• Patients who prefer rapid onset and shorter duration to avoid daytime sedation.

Conditions Where Oil Often Performs Better

• Chronic pain requiring sustained, all-day relief.
• Sleep disorders (taken before bed).
• Epilepsy — consistent blood levels are particularly important.
• Anxiety disorders where constant, background symptom management is needed.
• Patients with respiratory conditions.

Can You Use Both?

Many UK patients are prescribed a combination of both — typically oil as a baseline medication for sustained symptom management, with flower available for breakthrough symptoms. This combination approach is common for complex chronic pain and PTSD management.

Compare available UK medical cannabis products including both oil and flower options on LeafMe.

Summary

• Flower offers faster onset and higher bioavailability; oil provides longer duration and better precision.
• Oil is more discreet, cost-effective for many patients, and safer for those with respiratory conditions.
• Flower is preferable for breakthrough symptom management.
• Many patients benefit from a combination of both formats.
• Discuss your condition, lifestyle, and preferences with your prescriber to find the right approach.